Home › Endometrial Cancer › Mississippi › Jackson
Endometrial Cancer clinical trials in Jackson, MS
3 studies for Endometrial Cancer are looking for participants at sites in and around Jackson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RecruitingObservational study
- University of Mississippi Medical Center, Jackson
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
RecruitingPhase 3
- St. Dominic's Hospital ( Site 5004), Jackson
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RecruitingPhase 3
- Research Site, Jackson
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Chicago, IL25 studies
- Queens, NY25 studies
- Columbus, OH25 studies
Other studies in Jackson
- Obesity8 studies
- Overweight6 studies
- Steatotic Liver Disease5 studies
- Non-Small Cell Lung Cancer5 studies
- Lung Cancer5 studies
- Prostate Cancer5 studies
- Breast Cancer5 studies
- Sickle Cell Disease5 studies
- Heart Failure5 studies
- Type 2 Diabetes5 studies
- Burkitt Lymphoma4 studies
- Acute Myeloid Leukemia4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.